MEDEOR, Truffle Capital's new BioMedTech Fund, qualified by institutional investors through the Tibi committee
The management company has just unveiled its new Fund called Truffle MEDEOR
Truffle Capital marks its ambition while wishing to respect its DNA. The management company founded by Philippe Pouletty and Bernard-Louis Roques in 2001, and directed by Patrick Kron, has just lifted the veil on its new fund, named Truffle MEDEOR. "This vehicle could total between 600 and 800 million euros, if successfully raised. It would then be the largest European Fund in the field of MedTech", Philippe Pouletty then underlined.
Also to be discovered
Investors Search for Promising Covid Cures
The race to develop vaccines and treatments to build immunity to the novel coronavirus ...
Abivax Stock Soars as French Regulator Approves Testing of a Drug to Treat Covid-19
The French biotech company Abivax announced Thursday that it had received clearance from French regulators to begin a 1,000 patient trial ...